Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向

◆英語タイトル:Ontario Teachers' Pension Plan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1388
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ontario Teachers’ Pension Plan – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Ontario Teachers’ Pension Plan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ontario Teachers’ Pension Plan since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Ontario Teachers’ Pension Plan’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Ontario Teachers’ Pension Plan. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Ontario Teachers’ Pension Plan’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Ontario Teachers’ Pension Plan and its subsidiaries since 2007.
- Information about key financial and legal advisors for Ontario Teachers’ Pension Plan’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Ontario Teachers’ Pension Plan’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 49
Corporate Venturing – Overview 49
Corporate Venturing – Deal reports 50
PARTNERSHIP 68
Partnership – Overview 68
Partnership – Deal reports 69
DIVESTMENTS 71
Divestments – Overview 71
Divestments – Deal reports 72
APPENDIX 89
Contact Us 89
About MarketLine Financial Deals Database 89
Deal Definition and Methodology 91
About MarketLine 98

List of Tables
Table 1: Ontario Teachers' Pension Plan M&A volume and value trend (2014-YTD2018)
Table 2: Ontario Teachers' Pension Plan M&A activity by geography (2014-YTD2018)
Table 3: Ontario Teachers' Pension Plan corporate venturing volume and value trend (2014-YTD2018)
Table 4: Ontario Teachers' Pension Plan corporate venturing by geography (2014-YTD2018)
Table 5: Ontario Teachers' Pension Plan partnership volume and value trend (2014-YTD2018)
Table 6: Ontario Teachers' Pension Plan divestments volume and value trend (2014-YTD2018)
Table 7: Ontario Teachers' Pension Plan divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Ontario Teachers' Pension Plan M&A volume and value trend (2014-YTD2018)
Figure 2: Ontario Teachers' Pension Plan M&A activity by geography (2014-YTD2018)
Figure 3: Ontario Teachers' Pension Plan corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Ontario Teachers' Pension Plan corporate venturing by geography (2014-YTD2018)
Figure 5: Ontario Teachers' Pension Plan partnership volume and value trend (2014-YTD2018)
Figure 6: Ontario Teachers' Pension Plan divestments volume and value trend (2014-YTD2018)
Figure 7: Ontario Teachers' Pension Plan divestments by geography (2014-YTD2018)

★海外企業調査レポート[Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UDG Healthcare Plc (UDG):製薬・医療:M&Aディール及び事業提携情報
    Summary UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities …
  • Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • JP Elektroprivreda BiH d.d. Sarajevo (JPESR)-エネルギー分野:企業M&A・提携分析
    Summary JP Elektroprivreda BiH d.d. Sarajevo (Elektroprivreda BiH) is a utility company that generates, transmits, supplies, and trades electricity. It also exports and imports electricity, including the management of electricity system. The company generates electricity from coal and hydro sources. …
  • Oman Cables Industry (OCAI):企業の財務・戦略的SWOT分析
    Oman Cables Industry (OCAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oklahoma Medical Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute. The institute conducts disease research for human diseases such as lupus, alzheimer’s and diseases of aging, diabetics, cancer, children’s disease, autoimmune disease and heart diseases. Its portfolio …
  • Lixte Biotechnology Holdings Inc (LIXT):製薬・医療:M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …
  • Clay Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Clay Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. EyePoint dura …
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • 3D Systems Corporation:企業の戦略・SWOT・財務情報
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cofidis Participations S.A.:企業の戦略・SWOT・財務分析
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務分析
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • Global Franchise Group, LLC:企業の戦略・SWOT・財務情報
    Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆